BioInnovation Institute (BII). (6/2/22). "Press Release: High-quality Project from EMBL Is the First to Enter the Bio Studio Program". |
2022-06-02 |
Scienion GmbH. (6/1/22). "Press Release: Scienion Appoints Frauke Hein as CEO". Berlin. |
2022-06-01 |
UK Government (Office for Life Sciences). (5/27/22). "Press Release: UK Commits to Life Sciences Cooperation with Sweden". |
2022-05-27 |
Colorifix Ltd.. (5/27/22). "Press Release: £18m Series B Round Raised to Accelerate the Adoption of Our Sustainable Textile Dyeing Solutions". Cambridge. |
2022-05-27 |
Pancryos ApS. (5/24/22). "Press Release: Pancryos Announces Exclusive Global License Agreement for First in Class Macroencapsulation Device". Copenhagen. |
2022-05-24 |
Cinclus Pharma Holding AB. (5/20/22). "Press Release: Cinclus Pharma Has Carried Out a Successful Private Placement of approximately SEK 240m". Stockholm. |
2022-05-20 |
Synexa Life Sciences B.V.. (5/19/22). "Press Release: Synexa Life Sciences Acquires Finnish CRO Syrinx Bioanalytics to Expand Bioanalysis Capabilities". Leiden. |
2022-05-19 |
Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. |
2022-05-18 |
Avantium N.V.. (5/17/22). "Press Release: Avantium Awarded €3 Million EU Grant to Demonstrate the Electrochemical Conversion of CO2 to Consumer Products". Amsterdam. |
2022-05-17 |
Sofinnova Partners. (5/16/22). "Press Release: Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences". New York, NY & Paris. |
2022-05-16 |
Proteros Biostructures GmbH. (5/16/22). "Press Release: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca". Munich. |
2022-05-16 |
Artax Biopharma, Inc.. (5/11/22). "Press Release: Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases". Cambridge, MA. |
2022-05-11 |
Qiagen N.V.. (5/11/22). "Press Release: Qiagen Proposes Expansion of Supervisory Board. Dr. Eva Pisa Proposed as a New Member to the Supervisory Board". Venlo. |
2022-05-11 |
Novo Nordisk A/S. (5/10/22). "Press Release: Novo Nordisk and Flagship Pioneering Announce a Strategic Collaboration to Create a Portfolio of Transformational Medicines". Bagsværd & Cambridge, MA. |
2022-05-10 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (5/9/22). "Press Release: SHS Strengthens Finance Team. Lukas Maucher Joins Tübingen-based Private Equity Investor as CFO". |
2022-05-09 |
Bico Group AB. (5/6/22). "Press Release: Bico Acquires Allegro 3D, Adding New Light-based 3D Bioprinting Technology – Complementing the Existing Offering of Application Tailored products". |
2022-05-06 |
Sidekick Health. (5/5/22). "Press Release: Sidekick Raises $55M Series B to Drive Further Growth". Berlin, Boston & Reykjavik. |
2022-05-05 |
Engimmune Therapeutics AG. (5/3/22). "Press Release: Engimmune Therapeutics Raises CHF 15.5 Million in Seed Financing to Develop Novel T-cell Receptor Therapeutics". Basel. |
2022-05-03 |
Hemispherian AS. (5/3/22). "Press Release: Hemispherian Raises Seed Funding for Novel Cancer Therapeutics". Oslo. |
2022-05-03 |
BioPhero ApS. (5/3/22). "Press Release: BioPhero Closes First Sale". |
2022-05-03 |
Selexis S.A.. (5/2/22). "Press Release: JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA". Sunnyvale, CA. |
2022-05-02 |
Bico Group AB. (4/29/22). "Press Release: New Interim CFO at BICO". |
2022-04-29 |
Lifebit Biotech Ltd.. (4/28/22). "Press Release: The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine". London. |
2022-04-28 |
Moderna, Inc.. (4/27/22). "Press Release: Arpa Garay Joins Moderna as Chief Commercial Officer". Cambridge, MA. |
2022-04-27 |
Bico Group AB. (4/26/22). "Press Release: BICO’s CFO Gusten Danielsson Leaves His Assignment". |
2022-04-26 |
Symeres. (4/26/22). "Press Release: Symeres Acquires Organix Inc., Adding Lipids Expertise and a Strategic Foothold in the US". Nijmegen. |
2022-04-26 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/22/22). "Press Release: SHS and Yabeo Invest in the Leading Scandinavian Digital Health Platform Dr.Dropin". Tübingen & Oslo. |
2022-04-22 |
Recipharm AB. (4/11/22). "Press Release: Recipharm Completes US Biologics Acquisitions". |
2022-04-11 |
Mireca Medicines GmbH. (4/8/22). "Press Release: Mireca Signs Transformative Deal with Nasdaq-listed Graybug Vision". Tübingen. |
2022-04-08 |
H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby. |
2022-04-08 |
Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. |
2022-04-04 |
Lundbeckfonden. (4/4/22). "Press Release: Lundbeck Foundation Shifts into New Biotech Gear. New unit Raises Ambitions in Denmark – Lundbeckfonden BioCapital". |
2022-04-04 |
Bayer AG. (3/31/22). "Press Release: Bayer to Strengthen Global Pharmaceuticals Production Network. Planned Investments of around €2bn over Next Three Years [Not intended for U.S. and UK Media]". Berlin. |
2022-03-31 |
Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. |
2022-03-31 |
Zealand Pharma A/S. (3/30/22). "Press Release: Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations". Copenhagen & Boston, MA. |
2022-03-30 |
Novo Holdings A/S. (3/29/22). "Press Release: Qure.ai Raises $40 Million from Healthcare Investors Novo Holdings and HealthQuad". Copenhagen, Mumbai & New York, NY. |
2022-03-29 |
XNK Therapeutics AB. (3/29/22). "Press Release: XNK Therapeutics Raises SEK 132 Million to Accelerate Growth". |
2022-03-29 |
Abera Bioscience AB. (3/29/22). "Press Release: Abera Bioscience Signs Agreement with NorthX Biologics for GMP Manufacturing". |
2022-03-29 |
Biogentiy ApS. (3/23/22). "Press Release: Innovation Fund Denmark Is Investing in the Development of BioSWITCH by Biogenity". |
2022-03-23 |
Bavarian Nordic A/S. (3/21/22). "Press Release: Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets |
2022-03-21 |
Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. |
2022-03-16 |
Forbion Capital Partners. (3/14/22). "Press Release: Forbion Strengthens Its Team with the Appointments of Mathias Vinther and Vanessa Carle". Naarden. |
2022-03-14 |
Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. |
2022-03-10 |
Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim. |
2022-03-08 |
Mariana Oncology Inc.. (3/8/22). "Press Release: Mariana Oncology Appoints Karen Smith, M.D., Ph.D., as Independent Board Director". Cambridge, MA. |
2022-03-08 |
Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". |
2022-03-07 |
Microbiotica Ltd.. (3/7/22). "Press Release: Microbiotica Raises £50 Million ($67 Million) to Advance Pipeline of Microbiome-based Therapeutics". Cambridge. |
2022-03-07 |
EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". |
2022-03-01 |
Targovax ASA. (2/28/22). "Press Release: Targovax ASA Strengthens Management with Lubor Gaal as Chief Financial Officer". Oslo. |
2022-02-28 |
ECBF Management GmbH. (2/23/22). "Press Release: Growth Capital for Sustainable Transformation to a Bio-based Circular Economy. EU-initiated Impact Fund Oversubscribed with € 300 million". Luxembourg. |
2022-02-23 |
TargED Biopharmaceuticals B.V.. (2/22/22). "Press Release: TargED Biopharmaceuticals Raises EUR 39 Million in Series A Financing to Bring Groundbreaking Thrombolytic Treatment to Patients". Utrecht. |
2022-02-22 |
Onego Bio Ltd.. (2/22/22). "Press Release: Finnish Startup Onego Bio Ltd Raises EUR 10M in Seed Funding to Commercialize a Breakthrough Technology to Produce Egg White without Chickens". Helsinki. |
2022-02-22 |
Strike Pharma AB. (2/22/22). "Press Release: Strike Pharma Completes 45 MSEK Financing Round". Uppsala. |
2022-02-22 |
Vibalogics GmbH. (2/18/22). "Press Release: Vibalogics Acquired by Top Global CDMO Recipharm AB". |
2022-02-18 |
Recipharm AB. (2/18/22). "Press Release: Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand Its Biologics Offering in the US". |
2022-02-18 |
Recipharm AB. (2/18/22). "Press Release: Recipharm Expands Its Advanced Therapy Medicinal Products (ATMPs) Offering into Virotherapies with the Acquisition of Vibalogics". |
2022-02-18 |
Centauri Therapeutics Ltd.. (2/16/22). "Press Release: Centauri Therapeutics Closes £24 million GBP Series A Investment Round". London. |
2022-02-16 |
NMD Pharma A/S. (2/15/22). "Press Release: NMD Pharma Raises €35 Million in a New Financing". Aarhus. |
2022-02-15 |
Life Sciences Partners (LSP). (2/11/22). "Press Release: LSP Closes EUR 1 Billion Flagship Fund LSP 7 to Invest in Life Sciences Companies". Amsterdam. |
2022-02-11 |
Gubra ApS. (2/10/22). "Press Release: Gubra ApS and Silence Therapeutics plc Collaborate to Develop RNAi Therapies against Novel Liver-directed Targets from Gubra’s streaMLine Platform". Hørsholm. |
2022-02-10 |
AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA. |
2022-02-07 |
Centogene N.V.. (2/1/22). "Press Release: Centogene Announces Nomination of Kim Stratton as Chief Executive Officer". Cambridge, MA, Rostock & Berlin. |
2022-02-01 |
Medix Biochemica Oy. (2/1/22). "Press Release: Medix Biochemica Expands Its Molecular Diagnostics Business through the Acquisition of myPOLS Biotec". Espoo. |
2022-02-01 |
Recipharm AB. (2/1/22). "Press Release: Recipharm Acquires GenIbet to Bolster Biologics Offering". |
2022-02-01 |
Ribbon Biolabs GmbH. (1/31/22). "Press Release: Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology". Vienna. |
2022-01-31 |
Leo Pharma A/S. (1/31/22). "Press Release: Leo Pharma Appoints Christophe Bourdon as New CEO". Ballerup. |
2022-01-31 |
Metagenomi Inc.. (1/25/22). "Press Release: Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform". Emeryville, CA. |
2022-01-25 |
Cytovation AS. (1/25/22). "Press Release: Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy". Bergen. |
2022-01-25 |
CombiGene AB. (1/25/22). "Press Release: CombiGene Signs Agreement to Evaluate the Leading Gene Therapy Candidate within the Lipodystrophy Project CGT2". |
2022-01-25 |
Amniotics AB. (1/20/22). "Press Release: Amniotics Secures Funding of SEK 4,8 Million from Vinnova to Develop Stem Cell Therapies". |
2022-01-20 |
Wacker Chemie AG. (1/17/22). "Press Release: Plasmitec – Wacker Introduces Its Plasmid DNA Production Platform". Munich & San Diego, CA. |
2022-01-17 |
Wacker Chemie AG. (1/11/22). "Press Release: Wacker and Biosyntia Develop Large-Scale Production Process for Sustainable Biotin". Munich & Copenhagen. |
2022-01-11 |
Electrochaea GmbH. (1/7/22). "Press Release: Growth-Stage Power-to-Gas Company Electrochaea Closes Series D Financing Round". Munich. |
2022-01-07 |
Sound Bioventures Management AB. (1/4/22). "Press Release: Sound Bioventures Raises € 110 Million for New Biotherapeutics Venture Fund". Malmö & Copenhagen. |
2022-01-04 |
Onxeo S.A.. (1/3/22). "Press Release: Onxeo Appoints Julien Miara as New Interim CEO". Paris. |
2022-01-03 |
Novo Holdings A/S. (12/21/21). "Press Release: Novo Holdings Invests EUR 86 Million in 21st.BIO, a New Bioindustrial Scale-up Company Building on Technology Base from Novozymes". Copenhagen. |
2021-12-21 |
NorthSea Therapeutics B.V.. (12/17/21). "Press Release: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders". Amsterdam. |
2021-12-17 |
Glycomine, Inc.. (12/17/21). "Press Release: Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease". San Carlos, CA. |
2021-12-17 |
Argobio SAS. (12/16/21). "Press Release: Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement". Paris & Tallinn. |
2021-12-16 |
Bico Group AB. (12/16/21). "Press Release: Bico Has Entered into an Agreement to Acquire Biosero, a Leading Software Provider for Automated Workflows and Laboratory Connectivity". |
2021-12-16 |
CombiGene AB. (12/16/21). "Press Release: CombiGene and Spark Therapeutics Plan to Expand the Clinical Development Program to Include the U.S. as Well as Europe". |
2021-12-16 |
Bico Group AB. (12/15/21). "Press Release: Cellink and Nanoscribe Join Forces to Launch the Quantum X bio, the World’s Most Accurate 3D Bioprinter". |
2021-12-15 |
Novo Nordisk A/S. (12/13/21). "Press Release: Novo Nordisk Invests more than DKK 17 bn in Expansion of the Manufacturing Facilities in Kalundborg, Denmark". |
2021-12-13 |
Eir Ventures Partners AB. (12/9/21). "Press Release: Eir Ventures Closes Life Science Venture Fund at EUR122 million". Stockholm & Copenhagen. |
2021-12-09 |
Emergence Therapeutics AG. (12/7/21). "Press Release: Emergence Therapeutics Raises €87 Million Series A Financing to Advance Nectin-4 ADC". Duisburg. |
2021-12-07 |
Capsida Biotherapeutics Inc.. (12/7/21). "Press Release: Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO". Thousand Oaks, CA. |
2021-12-07 |
Eir Ventures Partners AB. (12/6/21). "Press Release: Eir Ventures Completes Investment in ArgusEye to Advance Innovative Sensor Technology for Real-time Monitoring of Bioproduction processes". Stockholm. |
2021-12-06 |
Bavarian Nordic A/S. (12/6/21). "Press Release: Bavarian Nordic A/S Announces Completion of Directed Issue of 6,373,680 New Ordinary Shares [Not for US, CA, JP, et al.]". Copenhagen. |
2021-12-06 |
Bavarian Nordic A/S. (12/6/21). "Press Release: Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base". Copenhagen. |
2021-12-06 |
Bavarian Nordic A/S. (12/5/21). "Press Release: Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate". Copenhagen. |
2021-12-05 |
Aqilion AB. (12/3/21). "Press Release: Aqilion Strengthens the Company’s Pipeline through the Acquisition of a Phase-1 Ready Anti-inflammatory Program from LEO Pharma". |
2021-12-03 |
AviadoBio Ltd.. (12/2/21). "Press Release: AviadoBio Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform". London. |
2021-12-02 |
Amarna Therapeutics B.V.. (12/1/21). "Press Release: Amarna Therapeutics Secures Additional €5 ($5.7) Million to Advance Its Transformative Gene Therapy Platform towards Clinical Trials". Leiden. |
2021-12-01 |
Immunovia AB. (11/30/21). "Press Release: Immunovia’s CEO to Step Down during 2022". Lund. |
2021-11-30 |
Novozymes A/S. (11/30/21). "Press Release: Novozymes Strengthens and Accelerates Its BioHealth-business by Acquiring a Majority Stake in Synergia Life Sciences, a Leading Developer and Manufacturer of Probiotics and Vitamin K2-7". |
2021-11-30 |
H. Lundbeck A/S. (11/29/21). "Press Release: Lundbeck Announces Changes to Executive Management". Valby. |
2021-11-29 |
HotSpot Therapeutics, Inc.. (11/29/21). "Press Release: HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic". Boston, MA. |
2021-11-29 |
Qlife Holding AB. (11/29/21). "Press Release: Qlife Recruits Kasper Damgaard Rousøe as New Chief Financial Officer". |
2021-11-29 |
Nykode Therapeutics A/S. (11/23/21). "Press Release: Nykode Therapeutics (formerly Vaccibody*)) Enters into Multi-target License and Collaboration Agreement with Regeneron to Develop Innovative Vaccines against Cancer and Infectious Diseases". Oslo. |
2021-11-23 |
Dicerna Pharmaceuticals, Inc.. (11/18/21). "Press Release: Novo Nordisk to Acquire Dicerna". Lexington, MA. |
2021-11-18 |